Literature DB >> 26182826

Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo.

Loukia Aketi, Pierre M Tshibassu, Patrick K Kayembe, Faustin Kitetele, Samuel Edidi, Mathilde B Ekila, Roger Wumba, François B Lepira, Michel N Aloni.   

Abstract

OBJECTIVES: The decision to initiate the antiretroviral therapy in HIV-infected children living in poor countries is compromised by lack of resources. The objective of this study is to identify simple clinical and biological markers other than CD4+ count and viral load measurement that could help the decision to introduce antiretroviral treatment and to monitor patients.
METHODS: A cross sectional study was conducted between January and March 2005 in Kinshasa, Democratic Republic of Congo.
RESULTS: Eighty-four children infected with HIV were recruited. In this cohort, the lymphocytes (P = 0.001) and CD4 (P = 0.0001) were significantly lower in children with immunological stage 3 and viral load (P = 0.027) was significantly higher in children at the same immunological stage. Reticulocytes (r = +0.440), white blood cells count (r = +0.560), total lymphocytes (r = +0.675) and albumin (r = +0.381) showed positive significant correlations with CD4. Haemoglobin (r = - 0.372), Haematocrit (r = - 0.248), red blood cells (r = - 0.278) and CD4 (r = - 0.285) showed negative significant correlations with viral load. Neutropaenia (P = 0.02), enlarged nodes (P = 0.005) and oral candidiasis (P = 0.04) were associated with viral load >10,000 copies/ml. Oral candidiasis (P = 0.02) was associated with CD4 level < 15%.
CONCLUSION: Oral candidiasis, enlarged nodes, total lymphocytes count, neutropaenia and albumin predict severe immunodepression. These clinical and biological markers may guide the clinician in making the decision to initiate antiretroviral therapy in highly resource-scarce settings.

Entities:  

Keywords:  Africa; Antiretroviral therapy,; CD4,; Children,; HIV,; Highly resource-scarce settings,; Kinshasa,; Simple markers,; The Democratic Republic of Congo,; Viral load,

Mesh:

Substances:

Year:  2015        PMID: 26182826      PMCID: PMC4727585          DOI: 10.1179/2047773215Y.0000000025

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  24 in total

1.  An evaluation of low-cost progression markers in HIV-1 seropositive Zambians.

Authors:  M Hosp; I M Lisse; M Quigley; A M Mwinga; P Godfrey-Faussett; J D Porter; N Luo; J Pobee; H Wachter; K P McAdam; D Fuchs
Journal:  HIV Med       Date:  2000-03       Impact factor: 3.180

2.  Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study.

Authors:  J G Feldman; D N Burns; S J Gange; P Bacchetti; M Cohen; K Anastos; M Nowicki; R Delapena; P Miotti
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

3.  Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.

Authors:  T E Taha; S M Graham; N I Kumwenda; R L Broadhead; D R Hoover; D Markakis; L van Der Hoeven; G N Liomba; J D Chiphangwi; P G Miotti
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

4.  Predictors of CD4+ lymphocyte count among HIV-seropositive and HIV-seronegative pregnant women in Dar es Salaam, Tanzania.

Authors:  S H Kapiga; D Mwakagile; D Spiegelman; G I Msamanga; D Hunter; W W Fawzi
Journal:  East Afr Med J       Date:  2000-04

5.  Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-04-24       Impact factor: 17.586

6.  Clinical spectrum of human immunodeficiency virus disease in children in a west African city. Project RETRO-CI.

Authors:  K M Vetter; G Djomand; F Zadi; L Diaby; K Brattegaard; M Timité; J Andoh; J A Adou; K M De Cock
Journal:  Pediatr Infect Dis J       Date:  1996-05       Impact factor: 2.129

7.  Surrogate markers of disease progression in HIV-infected children in Rio de Janeiro, Brazil.

Authors:  M B Ortigão-de-Sampaio; T F Abreu; M I Linhares-de-Carvalho; A Ponce de Leon; L R Castello-Branco
Journal:  J Trop Pediatr       Date:  1999-10       Impact factor: 1.165

8.  Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians.

Authors:  Yared Mekonnen; Nicole H Dukers; Eduard Sanders; Wendelien Dorigo; Dawit Wolday; Ab Schaap; Ronald B Geskus; Roel A Coutinho; Arnaud Fontanet
Journal:  AIDS       Date:  2003-04-11       Impact factor: 4.177

9.  Immunological manifestations of HIV-infected children.

Authors:  B S Eley; J Hughes; S Potgieter; M Keraan; J Burgess; G D Hussey
Journal:  Ann Trop Paediatr       Date:  1999-03

10.  Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important.

Authors:  J L Malone; T E Simms; G C Gray; K F Wagner; J R Burge; D S Burke
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.